Please enable JavaScript to continue using this application.

Compare $IMMX vs $VSTM | Chartloom

Compare

$IMMX vs $VSTM

Immix Biopharma Inc · Verastem Inc

IMMX

Immix Biopharma Inc

VSTM

Verastem Inc

Compare $IMMX vs $VSTM

Comparing Immix Biopharma Inc and Verastem Inc

IMMXImmix Biopharma Inc

VSTMVerastem Inc

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

VSTMVerastem Inc

Market cap

$736M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.92x

Rev growth (TTM)

3995.7%

YTD performance

15.9%

52W performance

-6.3%

FCF yield

-23.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMMX

VSTM

Detailed metrics comparison

IMMX

Immix Biopharma Inc

VSTM

Verastem Inc

Market Cap

IMMX$660M

VSTM$736M

Enterprise Value

IMMX$435M

VSTM$682M

Price

IMMX$9.46

VSTM$8.38

P/E Ratio

IMMXN/A

VSTMN/A

P/S Ratio

IMMX0.00x

VSTM8.41x

EV/Sales

IMMX0.00x

VSTM7.79x

EV/EBITDA

IMMX0.00x

VSTM0.00x

P/B Ratio

IMMX3.03x

VSTM14.07x

P/FCF Ratio

IMMXN/A

VSTMN/A

EV/FCF

IMMX-11.12x

VSTM-3.97x

PEG Ratio

IMMXN/A

VSTMN/A

Forward P/E (NTM)

IMMXN/A

VSTMN/A

Forward P/S (NTM)

IMMXN/A

VSTM4.92x

Revenue (TTM)

IMMX$0

VSTM$88M

Revenue Growth (YoY)

IMMXN/A

VSTM3995.7%

Forward Rev Growth

IMMX452.1%

VSTM61.6%

Gross Margin (TTM)

IMMX0.0%

VSTM87.6%

Operating Margin (TTM)

IMMX0.0%

VSTM0.0%

EBITDA Margin (TTM)

IMMX0.0%

VSTM-181.3%

Net Margin (TTM)

IMMX0.0%

VSTM-231.6%

FCF Margin (TTM)

IMMXN/A

VSTM-196.3%

Net Income (TTM)

IMMX$-40M

VSTM$-203M

FCF (TTM)

IMMX$-39M

VSTM$-172M

EPS (TTM)

IMMX-$0.63

VSTM-$2.02

ROE (TTM)

IMMX-3844.0%

VSTM-16540.0%

ROA (TTM)

IMMX-3472.0%

VSTM-9454.0%

ROIC (TTM)

IMMX-3844.0%

VSTM-7104.0%

Cash

IMMX$225M

VSTM$136M

Debt

IMMX$0

VSTM$82M

Net Cash/Debt

IMMX$225M

VSTM$55M

Current Ratio (TTM)

IMMX25.13x

VSTM2.25x

Quick Ratio (TTM)

IMMX24.98x

VSTM2.12x

Debt/Equity (TTM)

IMMX0.00x

VSTM1.63x

Debt/Assets (TTM)

IMMX0.0%

VSTM0.0%

Interest Coverage (TTM)

IMMXN/A

VSTMN/A

Net Debt/EBITDA (TTM)

IMMX0.00x

VSTM0.00x

Beta

IMMX0.22

VSTM0.58

52W Performance

IMMX272.4%

VSTM-6.3%

YTD Performance

IMMX74.2%

VSTM15.9%

% from 52W High

IMMX-37.4%

VSTM-22.6%

% from 52W Low

IMMX309.5%

VSTM144.3%

Asset Turnover (TTM)

IMMX0.00x

VSTM0.41x

FCF Yield (TTM)

IMMX-5.9%

VSTM-23.3%

Earnings Yield (TTM)

IMMX-6.0%

VSTM-27.5%

Dividend Yield (TTM)

IMMXN/A

VSTMN/A

Rule of 40

IMMX0.0

VSTM3,799.4

EV/GP/RG

IMMXN/A

VSTM0.13

Ticker research

View IMMX research View VSTM research

Metric	IMMX Immix Biopharma Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$660M	$736M
Enterprise Value	$435M	$682M
Price	$9.46	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.41x
EV/Sales	0.00x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.03x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.12x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	N/A	3995.7%
Forward Rev Growth	452.1%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-40M	$-203M
FCF (TTM)	$-39M	$-172M
EPS (TTM)	-$0.63	-$2.02
ROE (TTM)	-3844.0%	-16540.0%
ROA (TTM)	-3472.0%	-9454.0%
ROIC (TTM)	-3844.0%	-7104.0%
Financial Health
Cash	$225M	$136M
Debt	$0	$82M
Net Cash/Debt	$225M	$55M
Current Ratio (TTM)	25.13x	2.25x
Quick Ratio (TTM)	24.98x	2.12x
Debt/Equity (TTM)	0.00x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	0.58
52W Performance	272.4%	-6.3%
YTD Performance	74.2%	15.9%
% from 52W High	-37.4%	-22.6%
% from 52W Low	309.5%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.41x
FCF Yield (TTM)	-5.9%	-23.3%
Earnings Yield (TTM)	-6.0%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View IMMX research	View VSTM research

Valuation

P/S Ratio

IMMX

0.00x

VSTM

8.41x

EV/FCF

IMMX

-11.12x

VSTM

-3.97x

Growth & revenue

Revenue Growth TTM

VSTM

3995.7%

Forward Revenue Growth

IMMX

452.1%

VSTM

61.6%

Profitability & performance

Gross Margin

VSTM

87.6%

IMMX

0.0%

ROE

IMMX

-3844.0%

VSTM

-16540.0%

FCF Yield %

IMMX

-5.9%

VSTM

-23.3%

52-Week Performance

IMMX

272.4%

VSTM

-6.3%

Detailed metrics comparison

IMMX

Immix Biopharma Inc

VSTM

Verastem Inc

Market Cap

IMMX$660M

VSTM$736M

Enterprise Value

IMMX$435M

VSTM$682M

Price

IMMX$9.46

VSTM$8.38

P/E Ratio

IMMXN/A

VSTMN/A

P/S Ratio

IMMX0.00x

VSTM8.41x

EV/Sales

IMMX0.00x

VSTM7.79x

EV/EBITDA

IMMX0.00x

VSTM0.00x

P/B Ratio

IMMX3.03x

VSTM14.07x

P/FCF Ratio

IMMXN/A

VSTMN/A

EV/FCF

IMMX-11.12x

VSTM-3.97x

PEG Ratio

IMMXN/A

VSTMN/A

Forward P/E (NTM)

IMMXN/A

VSTMN/A

Forward P/S (NTM)

IMMXN/A

VSTM4.92x

Revenue (TTM)

IMMX$0

VSTM$88M

Revenue Growth (YoY)

IMMXN/A

VSTM3995.7%

Forward Rev Growth

IMMX452.1%

VSTM61.6%

Gross Margin (TTM)

IMMX0.0%

VSTM87.6%

Operating Margin (TTM)

IMMX0.0%

VSTM0.0%

EBITDA Margin (TTM)

IMMX0.0%

VSTM-181.3%

Net Margin (TTM)

IMMX0.0%

VSTM-231.6%

FCF Margin (TTM)

IMMXN/A

VSTM-196.3%

Net Income (TTM)

IMMX$-40M

VSTM$-203M

FCF (TTM)

IMMX$-39M

VSTM$-172M

EPS (TTM)

IMMX-$0.63

VSTM-$2.02

ROE (TTM)

IMMX-3844.0%

VSTM-16540.0%

ROA (TTM)

IMMX-3472.0%

VSTM-9454.0%

ROIC (TTM)

IMMX-3844.0%

VSTM-7104.0%

Cash

IMMX$225M

VSTM$136M

Debt

IMMX$0

VSTM$82M

Net Cash/Debt

IMMX$225M

VSTM$55M

Current Ratio (TTM)

IMMX25.13x

VSTM2.25x

Quick Ratio (TTM)

IMMX24.98x

VSTM2.12x

Debt/Equity (TTM)

IMMX0.00x

VSTM1.63x

Debt/Assets (TTM)

IMMX0.0%

VSTM0.0%

Interest Coverage (TTM)

IMMXN/A

VSTMN/A

Net Debt/EBITDA (TTM)

IMMX0.00x

VSTM0.00x

Beta

IMMX0.22

VSTM0.58

52W Performance

IMMX272.4%

VSTM-6.3%

YTD Performance

IMMX74.2%

VSTM15.9%

% from 52W High

IMMX-37.4%

VSTM-22.6%

% from 52W Low

IMMX309.5%

VSTM144.3%

Asset Turnover (TTM)

IMMX0.00x

VSTM0.41x

FCF Yield (TTM)

IMMX-5.9%

VSTM-23.3%

Earnings Yield (TTM)

IMMX-6.0%

VSTM-27.5%

Dividend Yield (TTM)

IMMXN/A

VSTMN/A

Rule of 40

IMMX0.0

VSTM3,799.4

EV/GP/RG

IMMXN/A

VSTM0.13

Ticker research

View IMMX research View VSTM research

Metric	IMMX Immix Biopharma Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$660M	$736M
Enterprise Value	$435M	$682M
Price	$9.46	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	8.41x
EV/Sales	0.00x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.03x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.12x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	N/A	3995.7%
Forward Rev Growth	452.1%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-40M	$-203M
FCF (TTM)	$-39M	$-172M
EPS (TTM)	-$0.63	-$2.02
ROE (TTM)	-3844.0%	-16540.0%
ROA (TTM)	-3472.0%	-9454.0%
ROIC (TTM)	-3844.0%	-7104.0%
Financial Health
Cash	$225M	$136M
Debt	$0	$82M
Net Cash/Debt	$225M	$55M
Current Ratio (TTM)	25.13x	2.25x
Quick Ratio (TTM)	24.98x	2.12x
Debt/Equity (TTM)	0.00x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	0.58
52W Performance	272.4%	-6.3%
YTD Performance	74.2%	15.9%
% from 52W High	-37.4%	-22.6%
% from 52W Low	309.5%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.41x
FCF Yield (TTM)	-5.9%	-23.3%
Earnings Yield (TTM)	-6.0%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View IMMX research	View VSTM research